Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Roundhill Glp-1 & Weight Loss ETF (OZEM)

Roundhill Glp-1 & Weight Loss ETF (OZEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Eli Lilly, Novo Nordisk Shares Climb Premarket As Biden Administration Mulls Medicare, Medicaid Covering For Obesity Drugs: Retail Unmoved Stocktwits - Tue Nov 26, 6:58AM CST

he new proposal would expand access to medications for obesity, and help an estimated 3.4 million Americans with Medicare.

NVO : 85.00 (-17.83%)
OZEM : 24.45 (-2.94%)
LLY : 767.76 (+1.35%)
IBB : 132.73 (+1.16%)
XBI : 91.28 (+1.64%)
Novo Nordisk Stock Falls Despite Strong Q3 Weight-Loss Drug Sales: Retail Shrugs Off Weakness Stocktwits - Wed Nov 6, 9:58AM CST

Novo Nordisk’s injectable weight-loss drug Wegovy sales climbed 79% year-over-year but overall sales growth was a touch soft.

NVO : 85.00 (-17.83%)
OZEM : 24.45 (-2.94%)
AVDE : 60.90 (-0.02%)
Tap the Weight-Loss Drug Market With These ETFs
Tap the Weight-Loss Drug Market With These ETFs Zacks Investment Research - Wed Sep 18, 11:15AM CDT

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 34.5000 (+0.76%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
HRTS : 29.15 (+0.28%)
THNR : 22.76 (-2.06%)
OZEM : 24.45 (-2.94%)
Invest in the GLP-1 Drug Market With This New ETF Baystreet - Tue Jun 4, 8:26AM CDT

The market for anti-obesity drugs is massive one, worth potentially $100 billion or more based on some ...

ZLDPF : 100.5100 (+0.71%)
LLY : 767.76 (+1.35%)
NVO : 85.00 (-17.83%)
OZEM : 24.45 (-2.94%)
ALT : 8.25 (+0.86%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot